KNC Laboratories Co., Ltd. (6568.T)
JPY 1098.0
(0.27%)
JPY 1098.0
(0.27%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 3.2 Billion | 1.99 Billion | 585.1 Million | 1.32 Billion | 42.2 Million |
| Net Income | 2.09 Billion | 2.17 Billion | 916.76 Million | 585.97 Million | 518.48 Million |
| Depreciation & Amortization | 922.36 Million | 919.07 Million | 929.26 Million | 939.6 Million | 803.15 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 900.81 Million | -738.75 Million | -1.14 Billion | -46.86 Million | -1 Billion |
| Other non-cash items | 152.74 Million | 64.3 Million | 203.16 Million | -521.98 Million | 2.56 Billion |
| Investing Cash Flow | -2.36 Billion | -1.14 Billion | -613.51 Million | -660.04 Million | -1.86 Billion |
| Investments in PPE | -2.35 Billion | -1.13 Billion | -833.37 Million | -892.07 Million | -1.94 Billion |
| Acquisitions | 1.15 Million | 27 Thousand | 485 Thousand | 666 Thousand | 80.23 Million |
| Investment purchases | -4.53 Million | -7.69 Million | -2.81 Million | -2.72 Million | -32.53 Million |
| Sales/Maturities of investments | 10.89 Million | 28.46 Million | - | 553 Thousand | 55.39 Million |
| Other Investing Activities | -22.26 Million | -37.44 Million | 222.19 Million | 233.48 Million | -18.68 Million |
| Financing Cash Flow | 178.86 Million | -523.39 Million | 39.01 Million | -180.14 Million | 254.99 Million |
| Debt repayment | -433.35 Million | -139.98 Million | -233.34 Million | -15 Million | -450.33 Million |
| Dividends payments | -254.39 Million | -271.64 Million | -193.9 Million | -193.53 Million | -192.84 Million |
| Common Stock Repurchased | -34 Thousand | -111.53 Million | - | - | -51 Thousand |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -62 Thousand | -227 Thousand | -424 Thousand | -1.61 Million | -2.43 Million |
| Accounts receivables | 165.32 Million | -272.77 Million | -1.37 Billion | 386.65 Million | -1.02 Billion |
| Accounts payables | -5.43 Million | 27.88 Million | 21.85 Million | 23.12 Million | -23.87 Million |
| Inventory | -238.4 Million | -507.97 Million | -29.08 Million | -457.19 Million | -188.51 Million |
| Other working capital | 1.13 Billion | 87.69 Million | 274.31 Million | -10.38 Million | 229.23 Million |
| Cash at beginning of period | 2.29 Billion | 1.97 Billion | 1.96 Billion | 1.47 Billion | 3.04 Billion |
| Cash at end of period | 3.31 Billion | 2.29 Billion | 1.97 Billion | 1.96 Billion | 1.47 Billion |
| Capital Expenditure | -2.35 Billion | -1.13 Billion | -833.37 Million | -892.07 Million | -1.94 Billion |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 1.01 Billion | 323.68 Million | 10.61 Million | 486.56 Million | -1.56 Billion |
| Free Cash Flow | 850.15 Million | 863.73 Million | -248.27 Million | 434.68 Million | -1.9 Billion |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | 2.09 Billion | 2.17 Billion | 916.76 Million | 585.97 Million | 518.48 Million |
| Depreciation & Amortization | 922.36 Million | 919.07 Million | 929.26 Million | 939.6 Million | 803.15 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 900.81 Million | -738.75 Million | -1.14 Billion | -46.86 Million | -1 Billion |
| Other non-cash items | 152.74 Million | 64.3 Million | 203.16 Million | -521.98 Million | 2.56 Billion |
| Investing Cash Flow | -2.36 Billion | -1.14 Billion | -613.51 Million | -660.04 Million | -1.86 Billion |
| Investments in PPE | -2.35 Billion | -1.13 Billion | -833.37 Million | -892.07 Million | -1.94 Billion |
| Acquisitions | 1.15 Million | 27 Thousand | 485 Thousand | 666 Thousand | 80.23 Million |
| Investment purchases | -4.53 Million | -7.69 Million | -2.81 Million | -2.72 Million | -32.53 Million |
| Sales/Maturities of investments | 10.89 Million | 28.46 Million | - | 553 Thousand | 55.39 Million |
| Other Investing Activities | -22.26 Million | -37.44 Million | 222.19 Million | 233.48 Million | -18.68 Million |
| Financing Cash Flow | 178.86 Million | -523.39 Million | 39.01 Million | -180.14 Million | 254.99 Million |
| Debt repayment | -433.35 Million | -139.98 Million | -233.34 Million | -15 Million | -450.33 Million |
| Dividends payments | -254.39 Million | -271.64 Million | -193.9 Million | -193.53 Million | -192.84 Million |
| Common Stock Repurchased | -34 Thousand | -111.53 Million | - | - | -51 Thousand |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -62 Thousand | -227 Thousand | -424 Thousand | -1.61 Million | -2.43 Million |
| Accounts receivables | 165.32 Million | -272.77 Million | -1.37 Billion | 386.65 Million | -1.02 Billion |
| Accounts payables | -5.43 Million | 27.88 Million | 21.85 Million | 23.12 Million | -23.87 Million |
| Inventory | -238.4 Million | -507.97 Million | -29.08 Million | -457.19 Million | -188.51 Million |
| Other working capital | 1.13 Billion | 87.69 Million | 274.31 Million | -10.38 Million | 229.23 Million |
| Cash at beginning of period | 2.29 Billion | 1.97 Billion | 1.96 Billion | 1.47 Billion | 3.04 Billion |
| Cash at end of period | 3.31 Billion | 2.29 Billion | 1.97 Billion | 1.96 Billion | 1.47 Billion |
| Capital Expenditure | -2.35 Billion | -1.13 Billion | -833.37 Million | -892.07 Million | -1.94 Billion |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 1.01 Billion | 323.68 Million | 10.61 Million | 486.56 Million | -1.56 Billion |
| Free Cash Flow | 850.15 Million | 863.73 Million | -248.27 Million | 434.68 Million | -1.9 Billion |
BTE
ITMPF
7131
NDA-SE
4561
5015